bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) shares rose 24.4% during mid-day trading on Thursday . The stock traded as high as $0.75 and last traded at $0.75. Approximately 1,000 shares changed hands during mid-day trading, a decline of 79% from the average daily volume of 4,789 shares. The stock had previously closed at $0.60.
bioAffinity Technologies Stock Performance
The company has a 50 day simple moving average of $0.98 and a 200 day simple moving average of $0.82.
About bioAffinity Technologies
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
Featured Articles
- Five stocks we like better than bioAffinity Technologies
- The Most Important Warren Buffett Stock for Investors: His Own
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Top Biotech Stocks: Exploring Innovation Opportunities
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Airline Stocks – Top Airline Stocks to Buy Now
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
